{'fraction_non_alphanumeric': 0.029505582137161084, 'fraction_numerical': 0.0023923444976076554, 'mean_word_length': 6.254335260115607, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Development of a large‐volume human‐derived adipose acellular allogenic flap by perfusion decellularization

In reconstructive surgery, transfer of patients’ tissue (autologous flaps) is routinely used to repair large soft tissue defects caused by surgery, trauma, chronic diseases, or malformations; unfortunately, this strategy is not always possible and often creates a secondary defect in the donor site of the tissue. Tissue‐engineered synthetic flaps are currently unable to repair clinically‐relevant, large‐volume defects; allogenic flaps from cadaveric donors could provide a ready‐to‐use biological alternative if treated with methods to avoid the immune‐rejection of the donor's cells. Here, we describe the successful decellularization of a large (> 800 cc) human‐derived adipose flap through a perfusion apparatus; we demonstrate the complete removal of the immunogenic cellular components of the flap with the retention of its structural components and vascular network. Our aim is to obtain a universally compatible, off‐the‐shelf acellular allogenic flap that could be recellularized with cells from recipient patients to provide a tissue‐engineered allogenic/autologous alternative for reconstruction of large‐volume soft‐tissue defects.